Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Net Margin (2016 - 2025)

Palisade Bio (PALI) has disclosed Net Margin for 14 consecutive years, with 57360.0% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin changed N/A to 57360.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 140837.5%, a N/A change, with the full-year FY2023 number at 5234.0%, changed N/A from a year prior.
  • Net Margin was 57360.0% for Q3 2025 at Palisade Bio, down from 139200.0% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 223000.0% in Q1 2025 to a low of 19688.46% in Q3 2021.
  • A 3-year average of 66524.92% and a median of 28786.99% in 2025 define the central range for Net Margin.
  • Biggest YoY gain for Net Margin was 5403154bps in 2021; the steepest drop was 3310025bps in 2021.
  • Palisade Bio's Net Margin stood at 19688.46% in 2021, then surged by 95bps to 936.0% in 2023, then soared by 6228bps to 57360.0% in 2025.
  • Per Business Quant, the three most recent readings for PALI's Net Margin are 57360.0% (Q3 2025), 139200.0% (Q2 2025), and 223000.0% (Q1 2025).